TABITHA SCHILLY: Open Payments
NPI 1720657729 · HENDERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 17 payments from 8 companies in 2025. Trend: 2023 $358 · 2024 $457 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Travere Therapeutics, Inc. | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| AKEBIA THERAPEUTICS INC | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| Novo Nordisk Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: JYNARQUE, FARXIGA, Fabhalta, Vafseo, Kerendia, Ozempic, JARDIANCE.
Industry payments across NC — which companies pay providers there.
